AMN Healthcare Services, Inc. (AMN)
NYSE: AMN · Real-Time Price · USD
22.38
+0.61 (2.80%)
At close: May 15, 2025, 4:00 PM
22.38
0.00 (0.00%)
After-hours: May 15, 2025, 7:00 PM EDT
AMN Healthcare Services Market Cap
AMN Healthcare Services has a market cap or net worth of $856.81 million as of May 15, 2025. Its market cap has decreased by -61.98% in one year.
Market Cap
856.81M
Enterprise Value
1.84B
1-Year Change
-61.98%
Ranking
Category
Stock Price
$22.38
Market Cap Chart
Since November 13, 2001, AMN Healthcare Services's market cap has decreased from $881.10M to $856.81M, a decrease of -2.76%. That is a compound annual growth rate of -0.12%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 14, 2025 | 833.50M | -8.48% |
| Dec 31, 2024 | 910.70M | -67.82% |
| Dec 29, 2023 | 2.83B | -36.49% |
| Dec 30, 2022 | 4.46B | -22.95% |
| Dec 31, 2021 | 5.78B | 80.17% |
| Dec 31, 2020 | 3.21B | 10.28% |
| Dec 31, 2019 | 2.91B | 9.61% |
| Dec 31, 2018 | 2.66B | 12.87% |
| Dec 29, 2017 | 2.35B | 27.35% |
| Dec 30, 2016 | 1.85B | 24.76% |
| Dec 31, 2015 | 1.48B | 62.02% |
| Dec 31, 2014 | 914.00M | 35.15% |
| Dec 31, 2013 | 676.30M | 31.91% |
| Dec 31, 2012 | 512.70M | 186.10% |
| Dec 30, 2011 | 179.20M | -25.36% |
| Dec 31, 2010 | 240.10M | -18.78% |
| Dec 31, 2009 | 295.60M | 7.26% |
| Dec 31, 2008 | 275.60M | -52.55% |
| Dec 31, 2007 | 580.80M | -38.02% |
| Dec 29, 2006 | 937.10M | 64.66% |
| Dec 30, 2005 | 569.10M | 26.19% |
| Dec 31, 2004 | 451.00M | -6.53% |
| Dec 31, 2003 | 482.50M | -33.63% |
| Dec 31, 2002 | 727.00M | -34.83% |
| Dec 31, 2001 | 1.12B | 26.61% |
View and export this data all the way back to 2001.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 670.25B |
| Johnson & Johnson | 357.09B |
| AbbVie | 332.70B |
| Novo Nordisk | 292.03B |
| UnitedHealth Group | 290.21B |
| Abbott Laboratories | 225.94B |
| Novartis AG | 213.30B |
| AstraZeneca | 210.42B |